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Background: Vitamin C (VitC) has recently been shown to exert beneficial effects, including protecting organ function
and inhibiting inflammation, in various critical care conditions, but the specific mechanism remains unclear. Induction
of heme oxygenase (HO)-1, a heat shock protein, has been shown to prevent organ injuries in hemorrhagic shock (HS)
but the relationship between VitC and HO-1 are still ill-defined so far. Here we conducted a systemic in vivo study to
investigate if VitC promoted HO-1 expression in multiple organs, and then tested if the HO-1 induction property of VitC
was related to its organ protection and anti-inflammatory effect.
Methods: Firstly, to determine the HO-1 induction property of VitC, the HO-1 level were measured in tissues including
kidney, liver and lung of the normal and HS model of Sprague–Dawley (SD) rats after VitC treatment (100 mg/kg body
weight). Secondly, to testify if VitC prevented HS related organ injuries via inducing HO-1, the HS model of rats were
separately pre- and post-treated with VitC, and some of them also received Zinc protoporphyrin (Znpp), a specific HO-1
inhibitor. The HO-1 activity in tissues was tested; the organ injuries (as judged by histological changes in tissues
and the biochemical indicators level in serum) and inflammatory response in tissues (as judged by the level of
pro-inflammatory cytokines Tumor necrosis factor-α and Interleukin-6 ) were analyzed.
Results: The HO-1 mRNA and protein level in kidney, liver, and lung were highly induced by VitC treatement under
normal and HS conditions. The HO-1 activity in tissues was enhanced by both VitC pre- and post-treatment, which
was shown to improve the organ injuries and inhibit the inflammatory response in the HS model of rats. Of note, the
beneficial effects of VitC were abolished after HO-1 activity was blocked by Znpp.
Conclusions: VitC led to a profound induction of HO-1 in multiple organs including the kidney, liver and lung, and
this property might be responsible for the organ protection and inflammation inhibitory effects of both pre- and
post-treatment with VitC in HS.Background
Hemorrhagic shock (HS) with trauma is the leading cause
of death for individuals aged 5 to 44 years [1]. Recent
clinical studies show that multiple organ failure (MOF)
remains common in patients with HS during the first two
days after admittance into the ICU, and the persistence
of MOF has been shown to be associated with a high
mortality rate [2]. To date, the prevention of MOF in the* Correspondence: chenerzhen@hotmail.com; maoeq@yeah.net
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Pro-inflammatory cytokines, such as tumor necrosis factor
(TNF)-α and interleukin (IL)-6, have been found to be
important in the development of MOF in patients with HS
[3]. Our previous study also showed that down-regulation
of TNF-α and IL-6 led to improvement in HS-related
organ injuries [4].
HO-1, also known as heat shock protein 32, is the
rate-limiting enzyme in heme catabolism [5,6] with the
anti-oxidant and anti-apoptosis effect. Recently, the
exogenous induction of heme oxygenase (HO)-1 has
received an increasing amount of attention due to its
anti-inflammatory potential. Over-expression of HO-1td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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enzymatic degradation of pro-inflammatory free heme [7],
but also through the production of the anti-inflammatory
compounds bilirubin and carbon monoxide (CO) [8]. It
has been demonstrated that exogenous induction of HO-1
exhibits protective effects on a number of organs, includ-
ing the kidneys [9], liver [10], and lungs [11] in the animal
model of HS.
Parenteral supplementation of vitamin C (VitC) was re-
cently shown to exert inflammation inhibitory and organ
protective effects in several different kinds of critical
conditions, such as sepsis [12], cardiac arrest [13] and
burn injury [14]. Recently, Schreiber et al. [15,16] showed
resuscitation with VitC decreased the level of IL-6 in
serum and lung tissue in a swine model of HS. However,
the specific mechanism through which VitC exerts these
beneficial effects has not been fully elucidated.
To the best of our knowledge, the studies on the rela-
tionship between VitC and HO-1 are sparse, and the
results seem contradictory. An early report [17] showed
that VitC significantly induced HO-1 expression in gastric
epithelial AGS and endothelial KATO IIIT, which might
correlate with gastro-protection properties. A study of
leukemia [18] showed that VitC potentiated the thera-
peutic efficacy of As3+ by enhancing the expression of
HO-1. Recently, VitC pretreatment was shown to induce
HO-1 expression in neurons and glial cells and attenuate
methamphetamine-induced reactive oxygen species (ROS)
production and neurotoxicity [19]. In contrast, VitC was
shown to inhibit the dopamine mediated HO-1 induction
in human umbilical vein endothelial cells in a dose-
dependent pattern [20], and partly antagonized resveratrol
mediated HO-1 induction in cultured hepatocytes [21].
Therefore, to determine the relationship between VitC
and HO-1 may help further elucidate the protective
mechnism of VitC.
For the first time, we conducted a systemic in vivo
study to determine if VitC induced HO-1 expression in
the kidneys, liver, and lungs which are relatively vulner-
able in the pathological process of HS. In order to mimic
more clinical situations, such as prophylactic therapy
in cases with a high risk of massive blood loss and the
rapid resuscitation for the trauma-hemorrhagic shock
patients, VitC was delivered before and after the estab-
lishment of HS model, and the organ injuries and pro-
inflammatory cytokines level were evaluated. To explore
the mediating role of HO-1, some VitC treated HS model
of rats further received the specific inhibitor of HO-1
activity, Zinc protoporphyrin (Znpp).
Methods
Animals
This study was carried out in strict accordance with the
guidelines for the care and use of laboratory animalsestablished by the Animal Use and Care Committee of the
Shanghai Committee on Animal Care. Animal surgical
procedures were approved by the Institutional Animal
Care and Use Committee (IACUC) at Shanghai Jiao Tong
University, Shanghai, China (Permit Number: SCXK
[shanghai] 2008–0016). Adult male Outbred Sprague–
Dawley (SD) rats (body weight = 250 ± 10 g) were pur-
chased from Shanghai Laboratory Animal Center (Chinese
Academy of Science, China) and housed under specific
pathogen-free conditions. The rats were provided rodent
chow and tap water ad libitum with a 12 hours/12 hours
light/dark cycle.
HS model
The establishment of the HS model was performed
according to the method described by Kana Umeda
et al. [22] with slight modifications. In brief, the rats were
anesthetized with intraperitoneal sodium pentobarbital
(50 mg/kg body weight). The left and right femoral artery
were dissected using aseptic techniques and cannulated
with a heparinized polyethylene tube. Catheters were
inserted into the left femoral artery to monitor blood
pressure (Powerlab 15 T, ADInstrument, Australia) and
into the right femoral artery to induce hemorrhage.
After the baseline blood pressure was measured, hemor-
rhage was initiated by bleeding into a heparinized syringe
(10 units/mL) over a period of 15 minutes to obtain a
mean arterial pressure of 30 mmHg. This blood pressure
level (30 ± 5 mmHg) was maintained for 1 hour by with-
drawing more blood or reinfusing the shed blood (average
bleeding volume: 6 ± 0.5 ml). As the HS operation was
completed, the animals were resuscitated for 15 minutes
by returning all of the shed blood and then administering
a volume of Ringer’s solution equal to the volume of
the shed blood. The Sham rats were cannulated but
were not subjected to hemorrhage. The rats were allowed
to breathe spontaneously throughout the experiment. To
maintain the body temperature within the physiological
range, all of the procedures were performed over a heating
pad, and the rectal body temperature was continuously
monitored. Electrocardiography was also continuously
measured.
Experimental design
To examine the effect of VitC treatment on HO-1 ex-
pression in the liver, kidney, and lung under normal
condition, rats were intraperitoneally injected with VitC
(100 mg/kg body weight, Sigma, St. Louis, MO, USA), as
described previously [23,24]. The VitC was dissolved in
normal saline (NS, 10 mg/ml) and filtered through a
0.45-μm filter (Millipore, Billerica, MA, USA) immediately
before use. Then, 2 to 2.5 mL of the VitC solution was
administered to each rat (the exact volume depended on
the weight of the animal). The control rats received the
Table 1 Sequences of the upstream and downstream
primers used in this study
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VitC or NS administration, the tissue samples including
kidneys, liver, and lungs were collected for further ana-
lyses. To further investigate the effect of VitC on tissue
HO-1 expression after HS, the rats underwent HS oper-
ation (HS group) and then immediately were intraperito-
neally treated with VitC (100 mg/kg body weight, HSV-post
group). Rats in the Sham and HS groups were given NS as
a control. The tissue samples were collected at 2, 6, 12,
24 hours after sham or HS operation for further analyses.
To investigate if pre- and post- treatment protected
against organ injuries in HS via the induction of HO-1,
the HS model of rats (HS group) were separately pre-
treated with VitC at 6 hours before HS operation (HSV-pre
group) and post-treated with VitC (100 mg/kg body
weight) immediately after the HS operation (HSV-post
group). Some rats in HSV-pre and HSV-post group further
received ZnPP (3 mg/kg body weight, Frontier) at 1 hour
before HS operation (HSV-preZ group and HSV-preZ group),
as previously described [25]. The rats undergone sham
(Sham group) received VitC (100 mg/kg body weight) at
6 hours before the sham operation (ShamV group). Some
rats in ShamV group further received Znpp at 1 hour
before the sham operation (ShamVZ group). The rats in
the Sham and HS groups were given NS as a control. At 0
and 12 hours after sham or HS operation, the tissue sam-
ples and serum were collected for further analyses.
Real-time PCR
After the samples were homogenized in liquid nitrogen, the
TRIzol Reagent (Invitrogen, USA) was added to the tissue
samples, and 2 μg of total RNA was extracted. The reverse
transcription reaction was conducted in a mixture contain-
ing random primers, RevertAid Reverse Transcriptase,
RNase inhibitor, and dNTP (all of the reagents were
obtained from Thermo Scientific Inc., Lithuania, EU) to
generate the single-strand cDNA. The PCR reaction mix-
ture was prepared using SYBR Premix Ex Taq (Takara Bio
Inc, Shiga, Japan) with the specific upstream and down-
stream primers for mRNA analysis. The thermal cycling
conditions were 10 seconds at 95°C for the initial denatur-
ation step followed by 40 cycles of 95°C for 5 seconds and
60°C for 20 seconds on a 7500 real-time PCR system (7500,
ABI, Foster, USA). The relative mRNA expression levels
were normalized to β-actin and calculated using the ΔΔCt
method. The HO-1 mRNA level was expressed relative to
the control group, and the mRNA levels of TNF-α and IL-6
were expressed relative to the Sham group. The sequences
of the upstream and downstream primers for HO-1, TNF-
α, IL-6, and β-actin are shown in Table 1.
Western-blot analysis
Equal amounts of protein extract (40 μg) from the kidney,
liver, and lung were loaded onto a 10% resolving gel forelectrophoresis. The proteins were transblotted onto a
Hypond polyvinylidene fluoride membrane (0.45 μm,
Millipore, Temecula, CA, USA). The membranes were
blocked by incubation in phosphate-buffered saline
containing 0.1% Tween 20 and 5% nonfat milk for
60 minutes at room temperature. The blot was immune-
probed with HO-1 primary antibody (1:1000 dilution,
Abcam, Cambridge, MA, USA) and an anti-β-actin anti-
body (1:1000 dilution, Santa Cruz Biotechnology, Dallas,
TX, USA) in succession overnight at 4°C. The blots were
then incubated with an HRP-conjugated secondary anti-
body for 1 hour at room temperature and then reacted
with an enhanced chemiluminescence substrate (Pierce,
Rockford, IL, USA). The resulting chemiluminescence was
recorded with an imaging system (Imagequant LAS 400,
GE, USA). To quantify the protein expression, the en-
hanced chemiluminescence signals were digitized using
the Photoshop CS6 software (Adobe, USA).
Immunohistochemistry
All of the protocols followed the guidelines of Histostain-
Plus Kits (Invitrogen, Frederick, MD, USA). Briefly, the
tissue samples were fixed in 10% neutral buffered for-
malin, embedded in paraffin, and sectioned into 4 to
6 μm-thick sections. After the antigen was retrieved in
a citrate buffer (0.01 M, pH 6.0) and subjected to heat
treatment using a microwave, the nonspecific binding
sites were blocked with 10% non-immune goat serum
for 30 minutes. The slides were then incubated at 4°C
overnight with a rabbit polyclonal HO-1 antibody
(1:400 dilution, Abcam, USA). The slides were further
incubated with biotinylated secondary antibody for
1 hour. Normal mouse serum was used as a control
for nonspecific staining. The images were collected
with a Zeiss microscope M1 (Jena, Germany).
HO-1 activity assay
The tissue samples were perfused in situ with NS until
the venous effluent became clear and then removed for
the preparation of microsomes. Based on the methods
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sured through the spectrophotometric determination of
the formation of bilirubin according to the manu-
facturer’s instructions (Genmed Scientifics, Arlington,
MA, USA). The amount of bilirubin in the tissue lysate
was determined by the difference in the absorbances at
464 and 530 nm using an extinction coefficient of
40 mM−1 cm−1. The enzymatic activity was expressed
as the picomoles of bilirubin formed per milligram of
cell protein per hour (pmol mg−1 h−1).
Histological study
The tissue samples were fixed in 10% neutral buffered
formalin, embedded in paraffin, and sectioned into 4 to
6 μm thick sections. After deparaffinisation and dehy-
dration, the sections were stained with hematoxylin and
eosin for microscopic examination. The histological
changes observed in the slides were blindly scored, as
described previously [27,28]. Briefly, the severity of renal
tubular injury was scored by estimating the percentage
of tubules in the cortex or the outer medulla that exhib-
ited epithelial necrosis or had luminal necrotic debris,
tubular dilation, and hemorrhage: 0, none; 1, <5%; 2, 5
to 25%; 3, 25 to 75%; and 4, >75%. The severity of liver
injury was scored as follows: 0, minimal or no evidence
of injury; 1, mild injury consisting of cytoplasmic vacuol-
ation and focal nuclear pyknosis; 2, moderate to severe
injury with extensive nuclear pyknosis, cytoplasmic hyper-
eosinophilia, and loss of intercellular borders; and 3,
severe necrosis with disintegration of the hepatic cords,
hemorrhage, and neutrophil infiltration. The severity of
lung injury was scored as follows: 0, no evidence of injury;
1, mild injury; 2, moderate injury; and 3, severe injury
with pulmonary edema, interstitial inflammatory cell
infiltration, and hemorrhage. All of the evaluations were
performed on five fields per section and five sections per
organ.
Analysis of serum biochemical indicators
As soon as collected, the arterial blood samples were imme-
diately centrifuged at 3,000 g for 15 minutes to obtain the
serum. The serum levels of alanine aminotransferase
(ALT), aspartate aminotransferase (AST), blood urea nitro-
gen (BUN), creatinine (Cre), lactic dehydrogenase (LDH),
and lactate were measured using an automatic biochemical
analyzer (UniCel DxC 800, Beckman Coulter, USA).
Enzyme linked immunosorbent assay
Protein levels of TNF-α and IL-6 in tissues were quantified
using an enzyme linked immunosorbent assay (ELISA) kit
(Mosaic ELISA system, R&D systems, Minneapolis, MN)
according to the manufacturer’s protocol. Samples were
measured in duplicate. Readings from each sample were
normalized for protein concentration.Statistical analysis
The statistical analysis was performed using Prism 4 soft-
ware (GraphPad Software, San Diego, CA, USA). All the
data are expressed as the mean ± SEM and compared
using the unpaired Student’s t-test and a one-way analysis
of variance followed by Turkey’s test. The differences with
a probability value of p < 0.05 were considered significant.
Results
HO-1 mRNA and protein expression in tissues were highly
induced under normal condition by VitC
Compared to NS, the VitC treatment induced a signifi-
cant and gradual increase of HO-1 mRNA and protein
level in the kidney, which reached a plateau at 24 hours
after VitC treatment (Figure 1Aa and 1Ba). The HO-1
mRNA level in the liver was markedly increased and
reached a maximum at 6 hours and was then gradually
decreased to around the base level at 24 hours after VitC
treatment (Figure 1Ab), and the protein level peaked at
2 hours and was decreased to the base level at 24 hours
after VitC treatment (Figure 1Bb). The HO-1 mRNA
level in the lung was gradually increased and reached a
maximum at 6 hours and was decreased to the base level
at 24 hours after VitC treatemtn (Figure 1Ac), and the
protein level was significantly increase at 6 hours and
peaked at 24 hours after VitC treatment (Figure 1Bc).
The immunohistochemistry analysis showed the distribu-
tion of the HO-1 protein at 6 hours after VitC treatment.
The positive staining of the HO-1 protein was mainly ob-
served in the renal tubular epithelial cells (Figure 1Cd),
the hepatic parenchymal cells (Figures 1Ce) and the lung
epithelial cells (Figure 1Cf), which are the targeted cells in
ischemic/reperfusion (I/R) injury of the liver and kidney
[29,30] as well as acute lung injury [31]. There was lit-
tle positive staining in the kidney (Figure 1Ca), liver
(Figure 1Cb), and lung (Figure 1Cc) of the Control rats.
The increased HO-1 mRNA and protein expression in
tissues after HS was enhanced by VitC
Compared to Sham group, the HO-1 mRNA level in
kidney of HS group was significantly increased at 2, 6, 12
and 24 hours after HS operation, which was enhanced by
VitC post-treatment (Figure 2Aa), while the HO-1 protein
level was significantly increased at 12 and 24 hours after
HS operation compared to Sham group, which was signi-
ficantly enhanced by VitC post-treatment at 2, 6 and
12 hours after HS operation (Figure 2Ba).
The HO-1 mRNA level in liver of HS group, signifi-
cantly increased at 2, 6, 12 and 24 hours after HS oper-
ation, was greatly enhanced VitC post-treatment at 2 and
6 hours after HS operation (Figure 2Ab), while the HO-1
protein level, significantly increased at 12 and 24 hours
after HS operation, was enhanced by VitC post-treatment
at 6 and 12 hours after HS operation (Figure 2Bb).
Figure 1 HO-1 mRNA and protein expression in tissues was highly induced under normal condition by VitC. A) HO-1 mRNA in the kidney
(a), liver (b), and lung (c) are expressed relative to the level measured in the control animals. B) HO-1 protein expression in the kidney (a), liver
(b), and lung (c) were detected using Western-blot. Each gel is representative of six independent experiments. Densitometric analysis was used
to calculate the normalized protein ratio (HO-1 to β-actin). C) distribution of HO-1 protein in the kidney (a, d, scale bar: 200 μm), liver (b, e, scale
bar: 100 μm), and lung (c, f, scale bar: 200 μm) were demonstrated by immunohistochemistry. The arrowheads indicate the HO-1-positive cells.
Each image is representative of six independent experiments (n = 6). Tissue samples were collected at 2, 6, 12 and 24 hours after VitC treatment.
Data represent the mean ± SEM. *p < 0.05 vs. the control. Control: normal saline-treated rats. V6h: the rats treated with VitC for 6 hrs.
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Figure 2 The increased HO-1 mRNA and protein expression in tissues after HS were enhanced by VitC. A) HO-1 mRNA in the kidney (a),
liver (b), and lung (c) are expressed relative to the level measured in Sham group. B) HO-1 protein expression in the kidney (a), liver (b), and lung (c) were
detected using Western-blot. Each gel is representative of six independent experiments. Densitometric analysis was used to calculate the normalized
protein ratio (HO-1 to β-actin). Tissue samples were collected at 2, 6, 12 and 24 hours after HS operation. Data represents the mean ± SEM. *p < 0.05
vs. the Sham; #p < 0.05 vs. the HS at the same time point. Sham: the rats which underwent sham operation and received normal saline (NS). HS: the
rats which underwent HS operation and received NS. HSV-post: the rats which underwent HS operation and then received VitC immediately.
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significantly increased at 2, 6 and 12 hours, while the
protein (Figure 2Bc) level reached the plateau at 12 and
24 hours after HS operation, both of which was greatly
up-regulated by VitC.HO-1 activity in tissues was highly enhanced by both VitC
pre- and post-treatment
As the HO-1 activity reflects the enzymatic function, it is
essential to investigate the effect of VitC pre- and post-
treatment on HO-1 activity in tissues. As the Figure 3
Figure 3 HO-1 activity in tissues was enhanced by both VitC pre- and post-treatment. Tissue samples were separately removed at 0 and
12 hours after sham or HS operation for HO-1 activity assay. *p < 0.05 vs. the Sham at the same time point; **p < 0.05 vs. the ShamV; ***p < 0.05
vs. the HS; ****p < 0.05 vs. the HSV-post. Data represents the mean ± SEM, n = 6. Sham: the rats which received NS and underwent sham operation;
ShamV: the rats which received VitC and underwent sham operation; ShamVZ: some ShamV rats further received ZnPP; HS: the rats which received NS
and underwent HS operation; HSV-post: the rats which underwent HS operation and then received VitC immediately; HSV-postZ: some HSV-post rats
further received ZnPP.
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tissues of ShamV group was significantly increased, which
was significantly reduced after the addition of Znpp. The
HO-1 activity in tissues was significantly increased at
12 hours after HS operation. The HO-1 activity in tissues
of HSV-post group, significantly higher than the level of
HS group, was decreased after the addition of Znpp.
Both VitC pre- and post-treatment relieved histological
damages through HO-1 induction
At 12 hours after HS operation, obvious histological
damage was observed in the kidneys, liver, and lungs
through hematoxylin and eosin staining. These damages
included epithelial necrosis, tubular dilation, and hemor-
rhage in the kidneys (Figure 4Ag), extensive nuclear pykno-
sis, hepatic cell necrosis, and hemorrhaging in the liver
(Figure 4Ah), and pulmonary edema, interstitial inflam-
matory cell infiltration, and hemorrhaging in the lungs
(Figure 4Ai). Both VitC pre- (Figures 4Aj-l) and post-
treatment (Figures 4A-r) improved the histological dam-
ages in HS group, and the beneficial effects of VitC were
attenuated by the addition of ZnPP (Figures 4Am-o and
4As-u). All of these histological changes were quantita-
tively evaluated using injury scores (Figure 4Ba-c).
Both VitC pre- and post-treatment decreased the serum
level of biochemical indicators through HO-1 induction
At 12 hours after HS operation, the serum was obtained
and the level of biochemical indicator including ALT
(Figure 5A), AST (Figure 5B), BUN (Figure 5C), Cre
(Figure 5D), LDH (Figure 5E) and lactate (Figure 5F)
were detected. All of the biochemical indicators were in-
creased in the HS group compared to the Sham group.
Both pre- and post-treatment with VitC significantlyreduced the levels of all of the indicators, which became
pronounced again after the addition of ZnPP.
Both VitC pre- and post-treatment decreased
proinflammatory cytokine levels in tissues through
HO-1 induction
As the HS related organ injuries were mainly ascribed to
proinflammatory cytokines [3], the levels of the proinflam-
matory cytokines TNF-α and IL-6 in the kidneys, liver and
lungs were tested at 12 hours after HS operation. The
TNF-α mRNA level in liver and lung (Figure 6A) and the
IL-6 mRNA level of liver (Figure 6C) elevated in HS group
compared to the Sham group, which were relieved by both
VitC pre- and post-treatment. This down-regulating effect
of VitC was abolished after the HO-1 activity was blocked
by the addition of ZnPP. The protein level of TNF-α
(Figure 6B) and IL-6 (Figure 6D) in the kidneys, liver,
and lungs exhibited a trend similar to that of mRNA
levels mentioned above after each treatment.
Discussion
In this study, we demonstrated that VitC treatment
induced HO-1 expression in the kidneys, liver, and lungs
under normal condition and enhanced HO-1 expression
after HS. Both pre- and post-treatment of VitC led to a
marked improvement in organ injuries and inflamma-
tory response. We also demonstrated that administration
of ZnPP inhibited HO-1 activity and negated the benefi-
cial effects of VitC treatment. These findings provide
more detailed evidences of the mechanism through
which VitC exerts a protective effect on HS.
HS and subsequent resuscitation is regarded as a sys-
temic I/R process that causes oxidative injuries of multiple
vulnerable organs including the liver [32], lung [33] and
Figure 4 Both VitC pre- and post-treatment relieved histological damages through HO-1 induction. A) representative light microscopy
images of the kidney (a, d, g, j, m, p, s, scale bar: 200 μm), liver (b, e, h, k, n, q, t, scale bar: 100 μm), and lung (c, f, I, l, o, r, u, scale bar: 200 μm),
which were stained with hematoxylin and eosin. B) histological damage score of the kidney (a), liver (b), and lung (c). Tissue samples were
collected at 12 hours after the HS operation. Data represents the mean ± SEM, n = 6. *p < 0.05 vs. the Sham; **p < 0.05 vs. the HS; ***p < 0.05 vs.
the HSV-pre; ****p < 0.05 vs. the HSV-post;
$p > 0.05 vs. the Sham. Sham: the rats which received NS and underwent sham operation. ShamV: the
rats which received VitC and underwent sham operation. HS: the rats which underwent HS operation and received NS. HSV-pre: the rats which
received VitC at 6 hours before HS operation. HSV-preZ: some HSV-pre rats further received ZnPP. HSV-post: the rats which underwent HS operation
and received VitC immediately. HSV-postZ: some HSV-post rats further received ZnPP.
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Figure 5 Both VitC pre- and post-treatment decreased the serum level of biochemical indicators through HO-1 induction. Serum level
of biochemical indicators including ALT (A), AST (B), BUN (C), Cre (D), LDH (E), and lactate (F) were tested. Serum was collected at 12 hours after
HS operation. Data represents the mean ± SEM, n = 6. *p < 0.05 vs. the Sham; **p < 0.05 compared to the HS; ***p < 0.05 compared to the HSV;
****p < 0.05 compared to the HSV-post;
$p > 0.05 compared to the Sham. Sham: the rats which received NS and underwent sham operation.
ShamV: the rats which received VitC and underwent sham operation. HS: the rats which received NS and underwent HS operation. HSV-pre: the
rats which received VitC at 6 hours before HS operation. HSV-preZ: some HSV-pre rats further received ZnPP. HSV-post: the rats which underwent HS
operation and received VitC immediately. HSV-postZ: some HSV-post rats further received ZnPP.
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sublethal stress, known as “organ preconditioning”, has
been shown to increase the tolerance of the organ to I/R
injuries. Several methods for “organ preconditioning” have
been reported, such as brief ischemia followed by reperfu-
sion [35], whole-body hyperthermia [36], and the induc-
tion of heat shock protein [37], such as HO-1, which is
also recognized as heat shock protein 32 [38]. Our study
showed the tissues level of HO-1 mRNA (Figure 1A) and
protein (Figure 1B) were greatly induced by VitC in normal
rats. Furthermore, the HO-1 activity in tissues (Figure 3),
which revealed the enzymatic function, were significantly
induced by VitC before initiation of hemorrhage. These
data confirmed the induction property of VitC and sug-
gested VitC pre-treatment can be considered as an efficient
method of “organ preconditioning”.However, the preconditioning situations make up a rela-
tively small portion of clinical situations. The majority of HS
patients are trauma-hemorrhagic patients who are in need
of rapid resuscitation. Therefore, it is necessary to investi-
gate the effects of VitC on HO-1 when administrated after
HS. Hsu et al. [39] reported resuscitation with estrogen pro-
tected cardiac function via enhancing HO-1 expression after
trauma-hemorrhagic shock. Consistent with their study, we
showed a general trend that VitC post-treatment enhanced
HO-1 mRNA (Figure 2A) and protein level (Figure 2B) and
HO-1 activity (Figure 3) after HS. This phenomenon recon-
firmed the HO-1 induction property of VitC and suggested
post-treatment with VitC might exert protective effect via
enhancement of HO-1 after HS. Additionally, we showed a
discrepancy of HO-1 mRNA and protein in the three
organs, and this phenomenon may be attributed to the
Figure 6 Both VitC pre- and post-treatment decreased the tissues level of proinflammatory cytokines through HO-1 induction. The mRNA
and protein levels of the proinflammatory cytokines TNF-α (A, B) and IL-6 (C, D) in tissues collected at 12 hours after HS operation were tested. The
data represents the mean ± SEM, n = 6. *p < 0.05 vs. the Sham; **p < 0.05 vs. the HS; ***p < 0.05 vs. the HSV-pre; ****p < 0.05 vs. the HSV-post. Sham:
the rats which received NS and underwent sham operation. ShamV: the rats which received VitC and underwent sham operation. HS: the rats which
received NS and underwent HS operation. HSV-pre: the rats which received VitC at 6 hours before HS operation. HSV-preZ: some HSV-pre rats further
received ZnPP. HSV-post: the rats which underwent HS operation and received VitC immediately. HSV-postZ: some HSV-post rats further received ZnPP.
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well as its tissue specific expression pattern [11].
However, pharmacological VitC is deemed as either a
pro-oxidant or an anti-oxidant depending on its concen-
tration which may lead to different consequences [42]. For
example, VitC, at the dose of 30 mg/kg, relieved hepatic
injuries in a rat model of hepatic ischemia/reperfusion,
but aggravated the hepatic injuries at the doses of
1000 mg/kg [43]. As a result, it is possible that the dose of
VitC used currently (100 mg/kg) might induce HO-1 ex-
pression as its pro-oxidant property and exert potential
adverse effect. We showed VitC treatment did not cause
obvious organ injuries in Sham rats according to the ana-
lyses of the histological changes (Figures 4Ad-f) and the
serum levels of various biochemical indictors (Figure 5).
Therefore, it is reckoned that the dose of VitC used in our
study was adequate to induce HO-1 expression due to its
pro-oxidant effect without disturbing normal organ physi-
ology and function. Similar to our findings, VitC has been
shown to kill tumor cells through the formation of ROS
but impart no adverse effects on normal cells in vitro [44].
At 12 hours after HS operation, obvious organ histo-
logical injuries were observed (Figure 4), accompanying
with the increased serum level of biochemical indicators
(Figure 5) which are the markers of organ function(ALT, AST, BUN and Cre) [45] and the indicator of HS
severity (LDH and lactate) [46,47]. The level of proin-
flammatory cytokines TNF-α and IL-6 in tissue were
also increased at the same time (Figure 6). Both pre- and
post-treatment with VitC was shown to lead to the
marked improvement of organ injuries and a decrease of
inflammatory cytokine levels. The benefits of VitC were
abolished by ZnPP, a HO-1 specific inhibitor, which was
shown to down-regulate the enhanced HO-1 activity fol-
lowing pre- or post-treatment with VitC (Figure 3). There-
fore, HO-1 is speculated to play an important role in
mediating the protective effect of VitC. Specifically, the
benefit of VitC pre-treatment might be related to “organ
preconditioning” by pre-induction of HO-1, and VitC
post-treatment exerted its beneficial effects by further
enhancing the expression of HO-1 induced by HS per se.
Conclusions
The present systemic study demonstrated that VitC treat-
ment induced HO-1 expression in the kidneys, liver, and
lungs in vivo. Both VitC pre- and post-treatment improved
the HS related organ injuries and the level of pro-
inflammatory cytokines via the induction of HO-1. Our
data further elucidates the mechanism of VitC for pre-
venting systemic injuries induced by HS.
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